Turkish Engineers Attained a Success for the First Time
An automatized bio-sensor device that can perform real-time electrochemical measurement has been co-designed for the first time by TÜBİTAK BİLGEM and GTÜ...
Turkish Engineers Attained a Success for the First Time
An electrochemical bio-sensor (MiSens) device that can instantly measure the effects of anticancer drugs on patients has been co-designed by TÜBİTAK Informatics and Information Security Research Center (BİLGEM) and Technical University of Gebze (GTÜ). The device is a first in the world being automatic and electrochemical.
An automatized bio-sensor device that can perform real-time electrochemical measurement has been co-designed for the first time by TÜBİTAK BİLGEM and GTÜ with the aim of running preview scan tests as a result of the need for methods that can detect the curing effects of drugs nowadays.
Through the device, the level of DNA fragmentation will be measured in a short time and its potential to be used as an anticancer drug will be tested, so that preview scan tests for biological activity will be tested using a new scanning method.
The device that has been designed will be used in many medical analyses, starting with the effects of anticancer drugs on DNA, at the Chemical Analysis - Biological Activity Test Laboratory of GTÜ.
"The device is a success story of an academic study turning into a product"
Speaking at the ceremony for the delivery of the device, Rector Prof. Dr. Haluk Görgün said that the device that was designed was a success story of an academic study turning into a product.
Prof. Görgün stated that the bio-sensor was a device co-designed by faculty members from the department of chemistry and researchers at BİLGEM with the aim of reducing the expenses and the damage of drugs used for the treatment of cancer, one of the biggest problems in the world.
"The bio-sensor is also a device that can detect the qualities of drugs used to treat cancer, which might harm the DNA in human body," Görgün added.
President of TÜBİTAK BİLGEM, Prof. Dr. Hacı Ali Mantar stated that within the scope of this study, conducted by TÜBİTAK BİLGEM and GTÜ cooperation, a device that performed real-time electrochemical measurement had been designed.
Emphasizing that the study is important in terms of being a tangible outcome of an academic collaboration and having a great effect, Prof. Mantar noted: "We hope that the following studies will result in tangible outcomes too. There is nothing to prevent us from having outcomes as this one."
After the speeches, the electrochemical bio-sensor (MiSens) was delivered to Prof. Görgün, the Rector of GTÜ, by Prof. Mantar.
"This is a domestic and national device"
TÜBİTAK BİLGEM National Research Institute of Electronics And Cryptology (UEKAE) Biology and Security Practices Unit Supervisor and Electrochemical Bio-sensor Project Unit Coordinator, Dr. Yıldız Uludağ spoke to an AA reporter and explained that the project had been designed and developed by a large team consisting of industrial designer, electronic, mechanical, chemical and software engineers, molecular biology and genetics specialists.
Stating that the bio-sensor (MiSens) is the smallest and the first full automatic device that performs electrochemical measurement in the world, Uludağ added:
"The device is multi-purpose. It can be used in R&D activities and the detection of medical diagnosis and disease symptoms. For example, it is possible to test the cancer bio-markers in blood or perform food analyses using this device. Whether the molecules harm the DNA in human cells or not is a very important criterion in using the device in R&D studies for our collaborative work with Technical University of Gebze to develop new drugs. It is possible with our device to perform these operations, which would normally require long and expensive processes with conventional methods, fast and automatically, and to scan a great number of molecules quickly. This is a completely domestic and national device which has been designed using the infrastructure of TÜBİTAK BİLGEM National Research Institute of Electronics And Cryptology (UEKAE). Our device is currently available for production and sales by BİLGEM for R&D purposes. Those who are interested in the device can contact BİLGEM and buy one."
(AA)
An automatized bio-sensor device that can perform real-time electrochemical measurement has been co-designed for the first time by TÜBİTAK BİLGEM and GTÜ with the aim of running preview scan tests as a result of the need for methods that can detect the curing effects of drugs nowadays.
Through the device, the level of DNA fragmentation will be measured in a short time and its potential to be used as an anticancer drug will be tested, so that preview scan tests for biological activity will be tested using a new scanning method.
The device that has been designed will be used in many medical analyses, starting with the effects of anticancer drugs on DNA, at the Chemical Analysis - Biological Activity Test Laboratory of GTÜ.
"The device is a success story of an academic study turning into a product"
Speaking at the ceremony for the delivery of the device, Rector Prof. Dr. Haluk Görgün said that the device that was designed was a success story of an academic study turning into a product.
Prof. Görgün stated that the bio-sensor was a device co-designed by faculty members from the department of chemistry and researchers at BİLGEM with the aim of reducing the expenses and the damage of drugs used for the treatment of cancer, one of the biggest problems in the world.
"The bio-sensor is also a device that can detect the qualities of drugs used to treat cancer, which might harm the DNA in human body," Görgün added.
President of TÜBİTAK BİLGEM, Prof. Dr. Hacı Ali Mantar stated that within the scope of this study, conducted by TÜBİTAK BİLGEM and GTÜ cooperation, a device that performed real-time electrochemical measurement had been designed.
Emphasizing that the study is important in terms of being a tangible outcome of an academic collaboration and having a great effect, Prof. Mantar noted: "We hope that the following studies will result in tangible outcomes too. There is nothing to prevent us from having outcomes as this one."
After the speeches, the electrochemical bio-sensor (MiSens) was delivered to Prof. Görgün, the Rector of GTÜ, by Prof. Mantar.
"This is a domestic and national device"
TÜBİTAK BİLGEM National Research Institute of Electronics And Cryptology (UEKAE) Biology and Security Practices Unit Supervisor and Electrochemical Bio-sensor Project Unit Coordinator, Dr. Yıldız Uludağ spoke to an AA reporter and explained that the project had been designed and developed by a large team consisting of industrial designer, electronic, mechanical, chemical and software engineers, molecular biology and genetics specialists.
Stating that the bio-sensor (MiSens) is the smallest and the first full automatic device that performs electrochemical measurement in the world, Uludağ added:
"The device is multi-purpose. It can be used in R&D activities and the detection of medical diagnosis and disease symptoms. For example, it is possible to test the cancer bio-markers in blood or perform food analyses using this device. Whether the molecules harm the DNA in human cells or not is a very important criterion in using the device in R&D studies for our collaborative work with Technical University of Gebze to develop new drugs. It is possible with our device to perform these operations, which would normally require long and expensive processes with conventional methods, fast and automatically, and to scan a great number of molecules quickly. This is a completely domestic and national device which has been designed using the infrastructure of TÜBİTAK BİLGEM National Research Institute of Electronics And Cryptology (UEKAE). Our device is currently available for production and sales by BİLGEM for R&D purposes. Those who are interested in the device can contact BİLGEM and buy one."
(AA)